USANA Health Sciences, Inc. (FRA:USJ)

Market Cap	308.21M
Revenue (ttm)	780.52M
Net Income (ttm)	14.53M
Shares Out	n/a
EPS (ttm)	0.77
PE Ratio	21.21
Forward PE	10.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	17.00
Previous Close	16.70
Day's Range	16.60 - 17.00
52-Week Range	15.70 - 37.60
Beta	n/a
RSI	47.29
Earnings Date	Feb 3, 2026

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 1,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: USJ

Financial Performance

In 2024, USANA Health Sciences's revenue was $854.50 million, a decrease of -7.22% compared to the previous year's $921.01 million. Earnings were $42.03 million, a decrease of -34.11%.

Financial numbers in USD